Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

600518.SS

Sell

Kangmei Pharmaceutical Co., Ltd. · Healthcare · China · $2.8B · Avg Vol: $39M/d

30
StockRank
Get insider-trade alerts
Q
48
V
29
M
41
P/E (TTM)
—
ROE
0.4%
D/E
0.0x
Dividend %
—
Dir. Trades · 180d
None →
Buybacks · 180d
None →

COMPANY DESCRIPTION

Kangmei Pharmaceutical Co., Ltd. engages in the production and sale of Traditional Chinese Medicine (TCM) decoction pieces, patent medicines, and healthcare products. The company maintains a broad distribution network and integrated supply chain across the TCM sector despite historical restructuring challenges. It is a major, vertically integrated player in the Chinese herbal medicine market recovering under state-backed strategic reorganization.

FINANCIAL SUMMARY (CNY)

Year2022202320242025CAGRTTM
Revenue4.2B4.9B5.2B5.3B7.9%5.0B
EPS (CNY)-0.190.010.000.00-73.5%—
Shares13.9B13.9B13.9B13.8B-0.3%13.8B
Debt263.9M255.0M139.1M184.4M-11.3%169.2M
Equity6.9B7.0B7.2B7.3B1.6%—
Op CF-750.0M-317.5M-427.6M111.3M—229.9M
Inv CF-46.0M-37.6M139.9M-177.3M——
Fin CF-116.9M-120.8M174.8M289.3M——
Loading 1Y...
PRICE (1Y)+1.5%
0.200.200.210.210.22Jul 17Aug 7Aug 27
SMA 50SMA 200

Close
$0.2068
RSI (14)
57.1
52W High
$0.3378
From 52W High
0.6%

SCORE BREAKDOWN

Quality
48
ROIC
0.8%48.0
ROE
0.4%47.3
GP/Assets
7.3%22.6
Op. Margin
-1.7%33.5
FCF/Assets
-0.8%43.5
Piotroski
999.2
Int. Cover
3.3x48.5
D/E Ratio
0.02x78.3
Current Ratio
1.31x20.5
Value
29
P/E (TTM)
—N/A
EV/EBITDA
370.0x1.4
P/FCF
—N/A
P/B
1.4x73.9
P/S
3.9x50.0
Div Yield
—N/A
Momentum
41
52W High %
61%36.9
RS 6M
—N/A
SMA 50/200
0.79x17.2
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
527%97.2

FUNDAMENTALS

Market Cap
$2.8B
P/E (Forward)
—
Gross Margin
19.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 600518.SS are excluded.

TickerCompanyMkt CapStockRankSignal
600518.SSKangmei Pharmaceutical Co., Ltd.(you)$2.8B30Sell
300723.SZApicHope Pharmaceutical Group Co., Ltd.$2.4B27Sell
600521.SSZhejiang Huahai Pharmaceutical Co., Ltd.$3.7B32Sell
300199.SZHybio Pharmaceutical Co., Ltd.$3.1B37Hold
002317.SZGuangdong Zhongsheng Pharmaceutical Co., Ltd.$3.2B38Hold
688131.SSShanghai Haoyuan Chemexpress Co., Ltd.$3.1B41Hold
002294.SZShenzhen Salubris Pharmaceuticals Co., Ltd.$5.3B30Sell
688185.SSCanSino Biologics Inc.$2.6B19Strong Sell
6887.HKSunshine Lake Pharma Co., Ltd.$2.9B45Hold
000661.SZChangchun High-Tech Industry (Group) Co., Ltd.$4.8B34Sell

Peer medians: ROE 4.5% · P/E 29.0x · Gross margin 52.6%

Kangmei Pharmaceutical Co., Ltd. (600518.SS): Stock Score Summary

Kangmei Pharmaceutical Co., Ltd. (600518.SS) has a MoatMap StockRank of 30/100 based on Quality (48/100), Value (29/100), and Momentum (41/100) factor scores. The current signal is SELL.

Kangmei Pharmaceutical Co., Ltd. engages in the production and sale of Traditional Chinese Medicine (TCM) decoction pieces, patent medicines, and healthcare products. The company maintains a broad distribution network and integrated supply chain across the TCM sector despite historical restructuring challenges. It is a major, vertically integrated player in the Chinese herbal medicine market recovering under state-backed strategic reorganization.

Key Financial Metrics

Price$0.21
Market Cap$2.8B
Price/Book1.42
Return on Equity0.4%
Return on Invested Capital0.8%
Debt/Equity0.02x
Gross Margin19.1%
Operating Margin-1.7%
Revenue Growth-5.3%
Free Cash Flow$-16M

Kangmei Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Kangmei Pharmaceutical Co., Ltd.’s (600518.SS) StockRank?
MoatMap’s StockRank for Kangmei Pharmaceutical Co., Ltd. (600518.SS) is 30/100, with a Sell signal. It is a composite of Quality (48), Value (29), and Momentum (41) factor ranks across MoatMap’s 20,000+ stock universe.
Does Kangmei Pharmaceutical Co., Ltd. have an economic moat?
Kangmei Pharmaceutical Co., Ltd. (600518.SS) has a Quality factor score of 48/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Kangmei Pharmaceutical Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Kangmei Pharmaceutical Co., Ltd. (600518.SS) is Sell, based on a StockRank of 30/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Kangmei Pharmaceutical Co., Ltd. in?
Kangmei Pharmaceutical Co., Ltd. (600518.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks600518.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock